Updated recommendations for the use of yellow fever vaccine

By  

Inpharma, Vol. 1, Iss. 1366, 2002-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Manage psychiatric and/or substance use comorbidities in patients with hepatitis C virus infection to improve antiviral outcomes

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 10, 2006-10 ,pp. : 14-17

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of new oral hepatitis C antiviral drugs

By Vispo Eugenia   Barreiro Pablo   Soriano Vicente  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 1, 2013-01 ,pp. : 5-16

Informa Healthcare

Access to resources Recommend Favorite

Antiviral therapy reduces HRQOL in patients with hepatitis C

By  

Reactions Weekly, Vol. 1, Iss. 1100, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Resistance of hepatitis C virus to the host antiviral response

By Polyak Stephen  

Future Virology, Vol. 1, Iss. 1, 2006-01 ,pp. : 89-98

Future Medicine

Access to resources Recommend Favorite